Pharmacoeconomic analysis of antifungal therapy for primary treatment of invasive candidiasis caused by Candida albicans and non-albicans Candida species

por Ou, Huang-Tz, Lee, Tsung-Ying, Chen, Yee-Chun, Charbonneau, Claudie
Publicado 2017

Value of hospital antimicrobial stewardship programs [ASPs]: a systematic review

por Nathwani, Dilip, Varghese, Della, Stephens, Jennifer, Ansari, Wajeeha, Martin, Stephan, Charbonneau, Claudie
Publicado 2019

An economic model to compare linezolid and vancomycin for the treatment of confirmed methicillin-resistant Staphylococcus aureus nosocomial pneumonia in Germany

por Patel, Dipen A, Michel, Andre, Stephens, Jennifer, Weber, Bertram, Petrik, Christian, Charbonneau, Claudie
Publicado 2014

1604. Cost-Effectiveness of Ceftazidime-Avibactam for Patients with Hospital-Acquired Pneumonia Caused by Multi-Drug Resistant Enterobacteriaceae or Pseudomonas in China

por Furnback, Wesley, Chen, YiXi, Dong, Peng, Wang, Bruce, Ansari, Wajeeha, Charbonneau, Claudie, Dong, Hengjing
Publicado 2020

Cost-effectiveness analysis comparing ceftazidime/avibactam (CAZ-AVI) as empirical treatment comparing to ceftolozane/tazobactam and to meropenem for complicated intra-abdominal in...

por Kongnakorn, Thitima, Eckmann, Christian, Bassetti, Matteo, Tichy, Eszter, Di Virgilio, Roberto, Baillon-Plot, Nathalie, Charbonneau, Claudie
Publicado 2019

Cost-effectiveness analysis of anidulafungin for the treatment of candidaemia and other forms of invasive candidiasis

por Auzinger, Georg, Playford, E. Geoffrey, Graham, Christopher N., Knox, Hediyyih N., Weinstein, David, Kantecki, Michal, Schlamm, Haran, Charbonneau, Claudie
Publicado 2015

Modeling the economic impact of linezolid versus vancomycin in confirmed nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus

por Patel, Dipen A, Shorr, Andrew F, Chastre, Jean, Niederman, Michael, Simor, Andrew, Stephens, Jennifer M, Charbonneau, Claudie, Gao, Xin, Nathwani, Dilip
Publicado 2014

Economic analysis of empiric versus diagnostic-driven strategies for immunocompromised patients with suspected fungal infections in the People’s Republic of China

por Mao, Ningying, Lesher, Beth, Liu, Qifa, Qin, Lei, Chen, Yixi, Gao, Xin, Earnshaw, Stephanie R, McDade, Cheryl L, Charbonneau, Claudie
Publicado 2016

Ceftaroline Fosamil for the Empiric Treatment of Hospitalized Adults with cSSTI: An Economic Analysis from the Perspective of the Spanish National Health System

por Torres, Antoni, Soriano, Alex, Rivolo, Simone, Remak, Edit, Peral, Carmen, Kantecki, Michal, Ansari, Wajeeha, Charbonneau, Claudie, Hammond, Jennifer, Grau, Santiago, Wilcox, Mark
Publicado 2022

Cost analysis of voriconazole versus liposomal amphotericin B for primary therapy of invasive aspergillosis among patients with haematological disorders in Germany and Spain

por Ostermann, Helmut, Solano, Carlos, Jarque, Isidro, Garcia-Vidal, Carolina, Gao, Xin, Barrueta, Jon Andoni, De Salas-Cansado, Marina, Stephens, Jennifer, Xue, Mei, Weber, Bertram, Charbonneau, Claudie
Publicado 2014

Cost-effectiveness analysis of voriconazole, fluconazole, and amphotericin B for invasive fungal infections following allogeneic hematopoietic stem cell transplantation in Mexico

por Morfín-Otero, Rayo, Alvarado-Ibarra, Martha, Rodriguez-Noriega, Eduardo, Resendiz-Sanchez, Jesus, Patel, Dipen A, Stephens, Jennifer M, Di Fusco, Manuela, Mendoza, Carlos F, Charbonneau, Claudie
Publicado 2018

Characterizing fatigue associated with sunitinib and its impact on health-related quality of life in patients with metastatic renal cell carcinoma

por Cella, David, Davis, Mellar P, Négrier, Sylvie, Figlin, Robert A, Michaelson, M Dror, Bushmakin, Andrew G, Cappelleri, Joseph C, Sandin, Rickard, Korytowsky, Beata, Charbonneau, Claudie, Matczak, Ewa, Motzer, Robert J
Publicado 2014

Burden and treatment patterns of invasive fungal infections in hospitalized patients in the Middle East: real-world data from Saudi Arabia and Lebanon

por Alothman, Adel F, Althaqafi, Abdulhakeem O, Matar, Madonna J, Moghnieh, Rima, Alenazi, Thamer H, Farahat, Fayssal M, Corman, Shelby, Solem, Caitlyn T, Raghubir, Nirvana, Macahilig, Cynthia, Charbonneau, Claudie, Stephens, Jennifer M
Publicado 2017

Cost-effectiveness analysis of combination antifungal therapy with voriconazole and anidulafungin versus voriconazole monotherapy for primary treatment of invasive aspergillosis in...

por Grau, Santiago, Azanza, Jose Ramon, Ruiz, Isabel, Vallejo, Carlos, Mensa, Josep, Maertens, Johan, Heinz, Werner J, Barrueta, Jon Andoni, Peral, Carmen, Mesa, Francisco Jesús, Barrado, Miguel, Charbonneau, Claudie, Rubio-Rodríguez, Darío, Rubio-Terrés, Carlos
Publicado 2016

The Use and Effectiveness of Ceftazidime–Avibactam in Real-World Clinical Practice: EZTEAM Study

por Soriano, Alex, Montravers, Philippe, Bassetti, Matteo, Klyasova, Galina, Daikos, George, Irani, Paurus, Stone, Gregory, Chambers, Richard, Peeters, Pascale, Shah, Mitesh, Hulin, Claire, Albuquerque, Natalia, Basin, Efim, Gaborit, Benjamin, Kourbeti, Irene, Menichetti, Francesco, Perez-Rodriguez, María Teresa, Pletz, Mathias W., Sanchez, Marisa, Trompa, Ivan, Verma, Anita, de Figueiredo, Maria Lavinea N., Charbonneau, Claudie
Publicado 2023